Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme / Reuteman-Fowler C. ... [et al.]. Psychiatria pre prax. Psychiatria pre prax 9. ročník : 22. - 24. november 2024, Tatranská Lomnica : odborný program a abstrakty Roč. 25, č. S2 (2024), s. 41-42